LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 2951 | 3124 | 0.9446 | 0.9266 |
Hs 578T | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 765 | 2629 | 3124 | 0.8416 | 0.7903 |
Hs 578T | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 765 | 396 | 3124 | 0.1270 | -0.1561 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 765 | 422 | 3124 | 0.1352 | -0.1453 |
Hs 578T | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2946 | 3124 | 0.9430 | 0.9245 |
Hs 578T | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 765 | 3127 | 3124 | 1.0010 | 1.0013 |
Hs 578T | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 765 | 3368 | 3124 | 1.0780 | 1.1033 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2868 | 3124 | 0.9179 | 0.8913 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2507 | 3124 | 0.8025 | 0.7384 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 524 | 3124 | 0.1679 | -0.1019 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 509 | 3124 | 0.1629 | -0.1085 |
Hs 578T | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 1291 | 3124 | 0.4134 | 0.2232 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 765 | 3051 | 3124 | 0.9766 | 0.9690 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3032 | 3124 | 0.9705 | 0.9609 |
Hs 578T | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 1295 | 3124 | 0.4147 | 0.2249 |
Hs 578T | R406 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2546 | 3124 | 0.8151 | 0.7551 |
Hs 578T | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 765 | 1791 | 3124 | 0.5733 | 0.4350 |
Hs 578T | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 3018 | 3124 | 0.9659 | 0.9549 |
Hs 578T | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 765 | 933 | 3124 | 0.2988 | 0.0715 |
Hs 578T | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 765 | 943 | 3124 | 0.3020 | 0.0757 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 765 | 2030 | 3124 | 0.6497 | 0.5361 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 765 | 1994 | 3124 | 0.6382 | 0.5209 |
Hs 578T | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 765 | 3046 | 3124 | 0.9750 | 0.9669 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 765 | 573 | 3124 | 0.1836 | -0.0811 |
Hs 578T | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 765 | 2221 | 3124 | 0.7110 | 0.6173 |